MENU
+Compare
GOSS
Stock ticker: NASDAQ
AS OF
Sep 26 closing price
Price
$2.70
Change
-$0.08 (-2.88%)
Capitalization
617.98M

GOSS Gossamer Bio Forecast, Technical & Fundamental Analysis

Gossamer Bio Inc is a clinical-stage biopharmaceutical company... Show more

GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GOSS with price predictions
Sep 26, 2025

GOSS in -9.70% downward trend, sliding for three consecutive days on September 26, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where GOSS declined for three days, in of 326 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for GOSS moved out of overbought territory on September 15, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on September 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GOSS as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GOSS turned negative on September 19, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

GOSS broke above its upper Bollinger Band on September 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where GOSS advanced for three days, in of 258 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 210 cases where GOSS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GOSS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.091) is normal, around the industry mean (19.823). P/E Ratio (0.000) is within average values for comparable stocks, (53.778). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.098). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (15.221) is also within normal values, averaging (349.540).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GOSS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GOSS is expected to report earnings to rise 11.00% to -18 cents per share on November 06

Gossamer Bio GOSS Stock Earnings Reports
Q3'25
Est.
$-0.19
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.01
The last earnings report on August 05 showed earnings per share of -17 cents, beating the estimate of -18 cents. With 3.93M shares outstanding, the current market capitalization sits at 617.98M.
A.I. Advisor
published General Information

General Information

a company, which engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
3013 Science Park Road
Phone
+1 858 684-1300
Employees
135
Web
https://www.gossamerbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFDSX23.740.20
+0.85%
DF Dent Small Cap Growth Investor
PSGAX26.260.18
+0.69%
Virtus KAR Small-Cap Growth A
MXXIX62.530.42
+0.68%
Marsico Midcap Growth Focus Fund
GEGTX86.520.33
+0.38%
Columbia Cornerstone Growth Inst
WIREX23.480.04
+0.17%
Wireless

GOSS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with ABEO. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then ABEO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
-2.88%
ABEO - GOSS
40%
Loosely correlated
+1.49%
SLDB - GOSS
35%
Loosely correlated
+3.89%
TERN - GOSS
35%
Loosely correlated
+2.69%
ATXS - GOSS
34%
Loosely correlated
+2.10%
XNCR - GOSS
34%
Loosely correlated
+12.00%
More